Biogen Sues USPTO Over Patent Term Adjustment
Biotechnology company Biogen Idec Inc. has sued the U.S. Patent and Trademark Office, seeking to have the patent term adjustment for a new cancer treatment extended by more than a year....To view the full article, register now.
Already a subscriber? Click here to view full article